Abstract
Introduction
Currently, many morbidities in preterms born at low birth weight and gestational week have decreased with improvements in premature infant care. However, as the survival chances of preterms born earlier have increased, a decrease in the frequency of bronchopulmonary dysplasia (BPD) has not been achieved. In this study, the risk factors of BPD, associated morbidities and its effect on mortality will be evaluated. Thus, it is aimed to decrease the incidence of BPD with new treatment and prevention strategies.
Materials and Methods
In this retrospective cohort study, preterms born in our hospital between January 2018 and December 2021 in the level 3 NICU less than 32 weeks of gestational age and/or 1500 g were included. The presence of BPD was determined in 2 groups as mild and moderate-severe BPD and associated risk factors and morbidities were evaluated.
Results
After the exclusion criteria were met, 363 preterm infants were included in the study. Of these babies, 33.1% (n=120) were diagnosed with BPD and 57.8% (n=69) of them were diagnosed with moderate-severe BPD. The frequency of BPD increased as birth weight and gestational week decreased. The risk of BPD increased significantly as the Apgar score decreased and the need for resuscitation increased (p<0.05). Respiratory distress syndrome(RDS) and patent ductus arteriosus(PDA) requiring treatment were observed more frequently in infants with a diagnosis of BPD(p<0.001). In patients with BPD, the incidence of ventilator-associated pneumonia(VAP), osteopenia of prematurity and retinopathy of prematurity(ROP) were found to be significantly higher (p<0.001). As a result of multivariate logistic regression analysis, it was found statistically significant that the likelihood of BPD increased 3.6-fold in infants with RDS, increased 6.2-fold in infants with VIP, and increased 4.6-fold in infants with osteopenia of prematurity.
Conclusion
The incidence of BPD and moderate to severe BPD is found to be increased in preterms. In the study, it was shown that the risk of BPD increased significantly in preterms with a history of VIP and accompanying osteopenia of prematurity. Bronchopulmonary dysplasia and moderate to severe BPD have been shown to be associated with mortality and it is thought that it is important to determine the risk groups for prevention.
Keywords: Bronchopulmonary dysplasia, prematurity, risk factors
References
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723-9.
Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, et al. Revisiting the definition of bronchopulmonary dysplasia:effect of changing panoply of respiratory support for preterm neonates. JAMA pediatrics. 2017;171:271-9.
Poindexter B, Feng R, Schmidt B, Aschner J, Ballard R, Hamvas A, et al. Prematurity and respiratory outcomes program. comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12:1822-30.
Isayama T, Iwami H, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis. JAMA. 2016;316:611-24.
Jensen EA, Edwards EM, Greenberg LT, Soll RF, Ehret DEY, Horbar JD. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics. 2021;148:e2020030007.
Yang T, Shen Q, Wang S, Dong T, Liang L, Xu F, et al. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study. BMC Pediatrics. 2022;22:200.
Korhonen P, Tammela O, Koivisto A-M, Laippala P, Ikonen S. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev. 1999;54:245-58.
Singh JK, Wymore EM, Wagner BD, Thevarajah TS, Jung JL, Kinsella JP, et al. Relationship between severe bronchopulmonary dysplasia and severe retinopathy of prematurity in premature newborns. J AAPOS. 2019;23:209.e1-209.e4.
Korkmaz A, Armangil D, Yurdakök M, Yiğit Ş, Tekinalp G, Profesörü HÜTFP. Long-term follow-up and rehospitalization characteristics of infants with bronchopulmonary dysplasia. J Child Health Dis. 2008;51:15-25.
Perrone M, Casirati A, Stagi S, Amato O, Piemontese P, Liotto N, e al. Don’t forget the bones: incidence and risk factors of metabolic bone disease in a cohort of preterm infants. Int J Mol Sci. 2022;23:10666.
Wang C, Ma X, Xu Y, Chen Z, Shi L, Du L. A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Front Pediatr. 2022;10:925312.
Arjaans S, Zwart EA, Ploegstra MJ, Bos AF, Kooi EM, Hillege HL, et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta‐analysis. Paediatr Perinat Epidemiol. 2018;32:258-67.
